Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin SR for Upper Respiratory Tract Infections in Japanese Adults
NCT00393835Phase 3Completed
- Sponsor
- Pfizer
- Start
- Nov 2006
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of azithromycin in laryngopharyngitis, tonsillitis and Acute bacterial rhinosinusitis (ABRS), sponsored by Pfizer. Primary endpoint: Investigator's Clinical Efficacy at Day 8. Started Nov 2006; status: completed.
02
Drugs
azithromycin
03
Conditions
laryngopharyngitistonsillitisAcute bacterial rhinosinusitis (ABRS)
Beyond the preview
Go deeper on NCT00393835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00393835.